PATENT CLAIM ANALYSIS

Application Number: 15893396
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "455000"]

Abstract:
The present invention relates to dosage forms of gallium complexes suitable for oral delivery and methods of preparation thereof. Such dosage forms are useful for the treatment of diseases, including, but not limited to, cancer.

Claim (Index 2):
The oral dosage form of  claim 1  wherein said GaQ3 is admixed with a dispersant.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 1.29032
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14211659', '11846896', '13052798', '13719640', '13657135']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7572584795740117
- 35 USC 102 Novelty (BERT): 0.5160309730510395
- Combined Prediction Score: 0.7331357289217145
- Mean Citation Score: 263.475926
- Max Citation Score: 274.77957000000004
- Similarity Product: 168.8415108221126

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test